EverSource Wealth Advisors’s Kalaris Therapeutics KLRS Stock Holding History

EverSource Wealth Advisors’s Portfolio KLRS Stock Details KLRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$241	Hold
2024 Q4	$292	Hold
2024 Q3	$562	Hold
2024 Q2	$515	Sell
2024 Q1	$1.06K	Buy
2023 Q3	–	Sell
2023 Q2	$541	Buy